Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for long-term sedation in obese mechanically ventilated ICU patients
ChiCTR2400089339Phase 4Not yet recruiting
- Sponsor
- Dazhou Central Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in obesity and respiratory failure (2 arms), sponsored by Dazhou Central Hospital. Primary endpoints: Hemodynamic changes during sedation, Success rate of sedation and 2 more. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
obesityrespiratory failure
Beyond the preview
Go deeper on ChiCTR2400089339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089339.